Nationwide GQG US Quality Eq R6 NWAVX

Medalist Rating as of | See Nationwide Investment Hub
  • NAV / 1-Day Return 17.08  /  −0.35 %
  • Total Assets 148.7 Mil
  • Adj. Expense Ratio
    0.490%
  • Expense Ratio 0.490%
  • Distribution Fee Level Below Average
  • Share Class Type Retirement, Large
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.35%
  • Turnover 205%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:17 PM GMT+0

Morningstar’s Analysis NWAVX

Will NWAVX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin Nationwide GQG US Quality Eq R6's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NWAVX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 49.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

9.28 14.0 Mil
Healthcare

Meta Platforms Inc Class A

6.93 10.5 Mil
Communication Services

Philip Morris International Inc

5.89 8.9 Mil
Consumer Defensive

Microsoft Corp

4.94 7.4 Mil
Technology

Novo Nordisk A/S ADR

4.90 7.4 Mil
Healthcare

Coca-Cola Co

4.26 6.4 Mil
Consumer Defensive

UnitedHealth Group Inc

3.94 5.9 Mil
Healthcare

Apple Inc

3.50 5.3 Mil
Technology

The Cigna Group

3.18 4.8 Mil
Healthcare

Walmart Inc

3.11 4.7 Mil
Consumer Defensive

Sponsor Center